RxDoctor Payments Data

CHILDRENS HOSPITAL

The Sunshine Act requires manufacturers to report payments to teaching hospitals as institutions, separately from payments to individual physicians. These figures are money reported to the hospital itself — most of it research funding and grants, not compensation to any named doctor.

Total reported
$10.3M
Transactions
1,535
Companies
40
Average per transaction
$6,715
← All teaching hospitals

Who reported the payments

Takeda Pharmaceuticals U.S.A., Inc.$3,985,834
Novartis$1,737,715
Jazz Pharmaceuticals Inc.$1,209,796
Travere Therapeutics, Inc.$515,320
Pfizer$318,930
Novo Nordisk AS$235,629
Merck$201,209
Hikma Pharmaceuticals USA$198,961
Janssen Research & Development, LLC$188,281
Eli Lilly$160,229
Shire North American Group Inc$150,000
E.r. Squibb & Sons, L.L.C.$119,101
Radiometer America, Inc$106,809
Philips North America LLC$105,000
Med-el Corporation$82,040
Sanofi$75,000
Siemens Medical Solutions USA, Inc.$66,660
Saol International Limited$66,494
Fisher Scientific Company L.L.C.$61,588
National Marrow Donor Program$41,640
Olympus America Inc.$39,961
Clearpoint Neuro, Inc.$39,280
Intuitive Surgical$38,807
Coaptech, Inc.$35,482
Leadiant Biosciences, Inc.$31,062
Sanofi US Services Inc.$29,363
Medtronic$26,413
AbbVie$25,655
Astrazeneca UK Limited$25,152
Berlin Heart Inc$24,970
Stryker$22,703
Teva Pharmaceuticals USA, Inc.$21,241
Kls-martin L.p.$20,619
Linvatec Corporation$20,256
Masimo Corporation$19,061
Qiagen, LLC$17,500
Astellas Pharma Global Development$17,000
Astellas US Technologies$16,892
KARL Storz Endoscopy-america$13,390
Biomarin Pharmaceutical Inc.$12,862